Keywords
Acute porphyria, Acute tubulointerstitial nephritis, Renal dysfunction, Renal biopsy, Interstitial fibrosis and tubular atrophy
This article is included in the Manipal Academy of Higher Education gateway.
Acute porphyria is a group of metabolic disorders characterized by a deficiency in enzymes involved in heme biosynthesis. A 21-year-old female with abdominal pain and an altered sensorium, eventually leading to a diagnosis of acute porphyria. Glucose treatment and other supportive measures were given and her general condition improved. Renal biopsy was done in view of persistent renal dysfunction, which revealed acute tubulointerstitial nephritis with 5-10% interstitial fibrosis and tubular atrophy. This Case highlights a unique manifestation of acute porphyria involving the kidney and emphasizes the importance of considering acute tubulointerstitial nephritis as a cause of renal dysfunction in acute porphyria.
Acute porphyria, Acute tubulointerstitial nephritis, Renal dysfunction, Renal biopsy, Interstitial fibrosis and tubular atrophy
Acute porphyria is a group of rare metabolic disorders characterized by enzyme deficiencies in heme biosynthesis.1,2 Acute porphyria primarily affects the nervous system and renal involvement is uncommon. Porphyrins are highly reactive to ultraviolet rays; in urine, they turn a reddish hue upon exposure to sunlight.3 There are various causes of renal failure in acute porphyria with acute interstitial nephritis (AIN), an infrequent manifestation characterized by interstitial inflammation and tubular injury. To our knowledge, this is the first case report of acute tubulointerstitial nephritis secondary to acute intermittent porphyria in India.
A 21-year-old female born to non-consanguineous parents presented with complaints of abdominal pain and altered sensorium. She had hypertension at presentation, neck stiffness, and a fundus within normal limits. All other systemic examination results were normal. Laboratory tests (Table 1) revealed normocytic normochromic anemia with deranged renal function tests and bland urine. Sepsis markers were standard, and the cultures were sterile. The ultrasonography results were within normal limits. ECG, 2 D Echo, and neuroimaging were performed, which was expected. Urine color provided a clue to evaluate the lines of porphyria, leading to the diagnosis of acute porphyria. Treatment included glucose administration and other supportive measures to improve the patient’s overall clinical condition. No nephrotoxic agents were used before admission, during the hospital stay, or after discharge from the hospital. She had persistent renal dysfunction for approximately six weeks following her acute episode. Hence, renal biopsy was done which revealed acute tubulointerstitial nephritis with early tubular chronicity (Figure 1 and Figure 2). She received oral steroids (0.5 mg/kg of prednisolone) for four weeks, after which she had normalization of renal function and was normotensive.
Renal lesions in patients with acute intermittent porphyria are attributed to hypertension but are not certain.3 Increased porphyrin metabolism during an attack is a plausible cause of renal impairment. During an acute episode, excess amounts of porphyrin metabolites that are produced can cause cytotoxic or vasospastic renal vascular lesions, inducing high blood pressure and later progressing to chronic hypertension.4 Other factors such as vasopressin and angiotensin may also be additives that cause kidney injury.
In a study by Andersson et al., 9 patients with acute intermittent porphyria who underwent renal biopsy had hypertension.5 Biopsies from these patients showed varying (slight to extensive) degrees of nephrosclerosis, with a mean of 50% globally sclerotic glomeruli, moderate tubular atrophy, and interstitial fibrosis with vessel wall thickening. Acute porphyria rarely presents as acute interstitial nephritis. The precise mechanism underlying the development of acute tubulointerstitial nephritis remains unclear; however, it is postulated that metabolic intermediates or porphyrin precursors may contribute to this. Therefore, interstitial fibrosis and tubular atrophy in renal biopsy imply an advanced phase of initial acute tubulointerstitial nephritis, which ultimately culminates in chronic interstitial nephritis and, thus, persistent renal dysfunction. Therefore, our case demonstrates that the metabolic intermediates/porphyrin precursors ignited the process of tubulointerstitial nephritis, which eventually led to early tubular chronicity, as seen in renal biopsy.
This case highlights the unique renal presentation of acute intermittent porphyria, thus emphasizing that clinicians should consider acute tubulointerstitial nephritis as a possibility in patients with acute porphyria presenting with unexplained renal dysfunction. Through this report, the literature includes acute intermittent porphyria as a possible cause of acute tubulointerstitial nephritis.
Written consent was obtained from the patient for publishing the case after de-identifying and anonymizing all patient identifiers.
All data underlying the results are available as part of the article and no additional source data are required.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Partly
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
References
1. Ricci A, Guida CC, Manzini P, Cuoghi C, et al.: Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications.Diagnostics (Basel). 2021; 11 (12). PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Inborn Errors of Metabolism. Neurodegenerative Disease. Clinical Trials
Is the background of the case’s history and progression described in sufficient detail?
No
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
No
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
No
Is the case presented with sufficient detail to be useful for other practitioners?
Partly
References
1. Cameron JS: Allergic interstitial nephritis: clinical features and pathogenesis.Q J Med. 1988; 66 (250): 97-115 PubMed AbstractCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: porphyrias, internal medicine
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
No
Is the case presented with sufficient detail to be useful for other practitioners?
No
References
1. Zhou XJ, Su T, Xie J, Xie QH, et al.: Genome-Wide Association Study in Acute Tubulointerstitial Nephritis.J Am Soc Nephrol. 2023; 34 (5): 895-908 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: acute porphyrias
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 1 02 May 24 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)